arrow
N

Norbert Suttorp

Berlin Institute of Health
H指数:88
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predicting the Risk of Intensive Care Unit Admission in Patients With Coronavirus Disease 2019 Presenting in the Emergency Room: Development and Evaluation of the Confusion, Respiratory rate, Oxygen Saturation With or Without Concurrent Supplemental Oxygen, and Oxygen Supplementation Score
2025-01-100
PRE
Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in COVID-19

肠道菌群失调与新型冠状病毒肺炎色氨酸代谢改变和炎症反应失调有关

2024-08-012
OAAI
Comparison of clinical outcomes in hospitalized patients with COVID-19 or non-COVID-19 community-acquired pneumonia in a prospective observational cohort study

前瞻性观察队列研究中新型冠状病毒肺炎或non-COVID-19社区获得性肺炎住院患者的临床结局比较

2024-05-181
OAAI
Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection

激活素A水平在人类结核病期间升高,激活素信号轴的阻断影响小鼠对结核分枝杆菌感染的反应

MBIO
IF4.7
2024-03-131
OAAI
Preclinical analyses reveal spleen tyrosine kinase as regulator of pulmonary vasoconstriction
2023-10-270
PRE
Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)

包括慢性发病在内的急性新型冠状病毒肺炎分析: 德国深度表型全国大流行队列网络方案 (NAPKON-HAP)

2023-07-112
OAAI
Pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH) in the German CAPNETZ-Cohort

德国CAPNETZ队列中HIV感染者 (PLWH) 的社区获得性肺炎病原体谱

2023-07-094
OAAI
Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patients

囊性纤维化跨膜传导调节调节剂可减弱健康供体和新型冠状病毒肺炎患者血液中的血小板活化和聚集

2023-03-230
OAAI
MicroRNA-223 Dampens Pulmonary Inflammation during Pneumococcal Pneumonia

MicroRNA-223抑制肺炎球菌肺炎期间的肺部炎症

CELLS
IF5.2
2023-03-214
OAAI
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial

Cenicriviroc治疗新型冠状病毒肺炎: 一项随机,安慰剂对照,研究者发起的双盲II期试验的第一个中期结果

2023-03-017
OAAI
Loss of endothelial CFTR drives barrier failure and edema formation in lung infection and can be targeted by CFTR potentiation

内皮CFTR的丧失驱动肺部感染中的屏障衰竭和水肿形成,并且可以通过CFTR增强作用来靶向

2022-12-0714
PRE
Transcriptomic comparison of primary human lung cells with lung tissue samples and the human A549 lung cell line highlights cell type specific responses during infections with influenza A virus

原代人肺细胞与肺组织样本和人A549肺细胞系的转录组比较突出了甲型流感病毒感染期间的细胞类型特异性反应

2022-11-295
OAAI
Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents

SARS-CoV-2感染后12个月的功能限制与初始疾病严重程度相关: 新型冠状病毒肺炎康复期心肺运动能力测试的观察性研究

2022-10-019
OAAI
Human alveolar progenitors generate dual lineage bronchioalveolar organoids

人肺泡祖细胞产生双谱系支气管肺泡类器官

2022-08-2510
OAAI
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics

执行和分析跨物种单肺细胞转录组学的肺科医师指南

2022-07-275
OAAI